Variable Deterioration in Cortical Function During Insulin-induced Hypoglycemia

Cortical function during insulin-induced hypoglycemia was studied in 14 normal controls and 12 type I diabetic patients by measuring the reaction time to a visual stimulus. Each subject was studied on two occasions, during insulin-induced hypoglycemia and under euglycemic conditions. The mean reaction time during euglycemic conditions was 260 ± 6 ms in the controls and 309 ± 11 ms in the diabetic subjects (P < 0.001) and did not change significantly over a 2-h period. Intravenous (i.v.) insulin administration to both groups of subjects resulted in similar reductions in glucose concentrations, which were maintained below 50 mg/dl for at least 30 min. Under these conditions, the reaction time increased significantly (mean increase 104 ± 37 ms [P < 0.02] in the controls and 75 ± 28 ms [P < 0.02] in the diabetic subjects). However, significant variability in responsiveness was observed in individual subjects. Three of the 14 controls and 4 of the 12 diabetic subjects showed no significant change in reaction time during hypoglycemia, while the remainder demonstrated significant increases. Individual differences were not correlated with severity or duration of hypoglycemia or counterregulatory hormone responses. The maximum increase in reaction time occurred as long as 60 min after the nadir glucose and returned to baseline 10–40 min after normalization (> 60 mg/dl) of the plasma glucose level. Subjective awareness of hypoglycemia was unrelated to the change in reaction time. These studies demonstrate that: (1) the reaction time to a visual stimulus is an objective, reproducible measure of cortical function during insulin-induced hypoglycemia; (2) control and diabetic subjects demonstrate variable sensitivity to the effects of hypoglycemia on cortical function, which is unrelated to the counterregulatory hormone responses; (3) the deterioration of cortical function observed during induction of hypoglycemia and the recovery of cortical function after euglycemia is restored may lag behind the changes in plasma glucose level (these findings help explain the frequently observed lack of correlation between the neurologic effects of hypoglycemia and simultaneous peripheral glucose levels); and (4) individual differences in cortical sensitivity as reflected by the reaction time response to hypoglycemia may parallel the variable clinical picture associated with hypoglycemia in insulin-treated diabetic subjects.

[1]  K. Polonsky,et al.  Glucose Counterregulation in Patients After Pancreatectomy: Comparison With Other Clinical Forms of Diabetes , 1984, Diabetes.

[2]  C. Ryan,et al.  Neuropsychological changes in adolescents with insulin-dependent diabetes. , 1984, Journal of consulting and clinical psychology.

[3]  J. Levy,et al.  Handwriting posture, visuomotor integration, and lateralized reaction-time parameters. , 1984, Human neurobiology.

[4]  J. Levy Is cerebral asymmetry of function a dynamic process? Implications for specifying degree of lateral differentiation , 1983, Neuropsychologia.

[5]  K. Polonsky,et al.  Lack of Glucagon Response to Hypoglycemia in Type I Diabetics After Long-Term Optimal Therapy with a Continuous Subcutaneous Insulin Infusion Pump , 1983, Diabetes.

[6]  C. Holmes,et al.  A Survey of Cognitive Functioning at Different Glucose Levels in Diabetic Persons , 1983, Diabetes Care.

[7]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[8]  K. Polonsky,et al.  Relation of counterregulatory responses to hypoglycemia in type I diabetics. , 1982, The New England journal of medicine.

[9]  T. Lauritzen,et al.  Absorption of isophane (NPH) insulin and its clinical implications. , 1982, British medical journal.

[10]  R. Hoeldtke,et al.  Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. , 1982, Annals of internal medicine.

[11]  P. Cryer,et al.  Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. , 1982, The Journal of clinical investigation.

[12]  A. Jensen,et al.  Reaction Time and Psychometric g , 1982 .

[13]  P. Cryer Glucose Counterregulation in Man , 1981, Diabetes.

[14]  P. Cryer,et al.  Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.

[15]  A. Jensen,et al.  Chronometric analysis of intelligence , 1980 .

[16]  R. DeFronzo,et al.  Stimulation of Counterregulatory Hormonal Responses in Diabetic Man by a Fall in Glucose Concentration , 1980, Diabetes.

[17]  D. Ewing,et al.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. , 1980, Annals of internal medicine.

[18]  R. Rizza,et al.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.

[19]  J. Sosenko,et al.  Glycosylated Hemoglobins: Increased Glycosylation of Hemoglobin A in Diabetic Patients , 1979, Diabetes.

[20]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[21]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[22]  A. Katz,et al.  Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure. , 1976, The Journal of clinical investigation.

[23]  J. Pappenheimer,et al.  Cerebral glucose transport and oxygen consumption in sheep and rabbits , 1973, The Journal of physiology.

[24]  G. Ross,et al.  Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle stimulating hormones. , 1967, The Journal of laboratory and clinical medicine.

[25]  B. Murphy,et al.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. , 1967, The Journal of clinical endocrinology and metabolism.

[26]  D. Lindsley,et al.  Reaction time and EEG activation under alerted and nonalerted conditions. , 1959, Journal of experimental psychology.